HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection-Reference-Cited by-同舟云学术

HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection

Published:2003-07-19 Issue:1 Volume:3 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Vamvakopoulos Joannis E,Green Colin

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2261-3-6.pdf

Reference46 articles.

1. Julius BK, Attenhofer Jost CH, Sutsch G, Brunner HP, Kuenzli A, Vogt PR, Turina M, Hess OM, Kiowski W: Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation. Transplantation. 2000, 69: 847-853.

2. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT: Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol. 1996, 7: 330-335.

3. Shi C, Lee W-S, He Q, Zhang D, Fletcher DL, Newell JB, Haber E: Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci USA. 1996, 93: 4051-4056. 10.1073/pnas.93.9.4051.

4. Boyle JJ, Bowyer DE, Weissberg PL, Bennett MR: Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand / Fas interactions. Arterioscler Thromb Vasc Biol. 2001, 21: 1402-1407.

5. Azuma H, Nadeau KC, Ishibashi M, Tilney NL: Prevention of functional, structural and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. Transplantation. 1995, 60: 1577-1582.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The changing landscape of thyroid eye disease: current clinical advances and future outlook;Eye;2024-02-19

2. Statins in Graves Orbitopathy: A New Therapeutic Tool;Ophthalmic Plastic & Reconstructive Surgery;2023-12

3. Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy;Frontiers in Endocrinology;2020-01-22

4. Atorvastatin inhibits pyroptosis through the lncRNA NEXN-AS1/NEXN pathway in human vascular endothelial cells;Atherosclerosis;2020-01

5. Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors;PLOS ONE;2017-12-18